Latest Share Price Movements News

Western Gold Resources has voluntarily suspended its shares from trading as it prepares to disclose details of a significant agreement and respond to an ASX price query.

Northern Minerals Limited has responded to ASX inquiries about recent unusual trading activity, confirming no undisclosed information but highlighting ongoing project developments and market factors influencing its share price.

Redox Limited has dismissed any undisclosed information behind its recent share price plunge, attributing the volatility to analyst downgrades and broader economic concerns.

Evolution Energy Minerals (EV1) addresses ASX queries over recent share price and volume spikes, attributing the activity to a subsidiary’s new US$2 million term sheet while confirming no undisclosed information.

Fisher & Paykel Healthcare has announced an ordinary dividend of NZD 0.28235294 per share for the six months ending March 31, 2025, payable on July 4. The dividend is unfranked and includes a supplementary component, with a 15% withholding tax applied.

INOVIQ Limited clarifies recent share price movements, confirming no undisclosed material information while highlighting an imminent ASCO presentation and provisional patent application tied to its EXO-OC ovarian cancer test.

Unith Ltd has responded to an ASX price query following unusual trading activity, denying undisclosed information and pointing to a successful recent roadshow as a potential factor.

First Au Limited’s trading suspension has been lifted following its announcement of a significant gold asset acquisition, signaling renewed market activity for the miner.

Liontown Resources has responded to an ASX query following a sharp rise in its share price and trading volume, denying any undisclosed information and confirming compliance with listing rules.

Heavy Minerals Limited attributes its recent share price jump to media coverage about its upcoming Port Gregory Pre-Feasibility Study and confirms compliance with ASX disclosure rules.

Nimy Resources has clarified that no undisclosed information explains its recent share price jump, pointing instead to ongoing drilling and positive media coverage about a gallium discovery.

Botanix Pharmaceuticals has clarified that recent share price movements are linked to a rumored US executive order on drug pricing, confirming no undisclosed material information. The company reassures investors of compliance with ASX disclosure rules amid market speculation.